Diabetic Nephropathy

• FDA approval · 2009-05-29
  FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  The FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC, enabling continued access to lisinopril…

• FDA approval · 2008-06-18
  FDA Approved: RAMIPRIL — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for ramipril, authorizing the marketing of a generic ramipril product.

• FDA approval · 2007-11-13
  FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)

  FDA approved Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril), approving an additional change to the approved ANDA…

• FDA approval · 2006-07-03
  FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)

  The FDA approved Camber Pharmaceuticals' supplemental application for lisinopril, authorizing the continued marketing of its lisinopril gene…

• FDA approval · 2006-06-08
  FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))

  The FDA issued approval for a supplemental application for lisinopril from Heritage Pharmaceuticals (Avet), authorizing marketing of a gener…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.